UA97376C2 - Vaccine - Google Patents

Vaccine

Info

Publication number
UA97376C2
UA97376C2 UAA200901962A UAA200901962A UA97376C2 UA 97376 C2 UA97376 C2 UA 97376C2 UA A200901962 A UAA200901962 A UA A200901962A UA A200901962 A UAA200901962 A UA A200901962A UA 97376 C2 UA97376 C2 UA 97376C2
Authority
UA
Ukraine
Prior art keywords
vaccines
against polio
protecting against
vaccine
polio
Prior art date
Application number
UAA200901962A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Гемптінн Герв Де
Мікель Дюкен
Енн Марі
Марк Сонвіаюкс
Original Assignee
Глаксосмітклайн Байолоджікалз С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0625593A external-priority patent/GB0625593D0/en
Application filed by Глаксосмітклайн Байолоджікалз С.А. filed Critical Глаксосмітклайн Байолоджікалз С.А.
Priority claimed from PCT/EP2007/059390 external-priority patent/WO2008028956A1/en
Publication of UA97376C2 publication Critical patent/UA97376C2/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The present invention relates to the field of vaccines for protecting against polio, and in particular to combination vaccines for protecting against polio, diphtheria, tetanus, and pertussis diseases. Specifically, vaccines comprising reduced dose inactivated poliovirus (IPV) is provided, which can maintain an adequate or improved level of protection against polio.
UAA200901962A 2006-09-07 2007-09-07 Vaccine UA97376C2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0617602.8A GB0617602D0 (en) 2006-09-07 2006-09-07 Vaccine
GB0625593A GB0625593D0 (en) 2006-12-21 2006-12-21 Vaccine
PCT/EP2007/059390 WO2008028956A1 (en) 2006-09-07 2007-09-07 Vaccine

Publications (1)

Publication Number Publication Date
UA97376C2 true UA97376C2 (en) 2012-02-10

Family

ID=37232508

Family Applications (2)

Application Number Title Priority Date Filing Date
UAA200901962A UA97376C2 (en) 2006-09-07 2007-09-07 Vaccine
UAA200901646A UA95810C2 (en) 2006-09-07 2007-09-07 Inactivated poliovirus vaccine

Family Applications After (1)

Application Number Title Priority Date Filing Date
UAA200901646A UA95810C2 (en) 2006-09-07 2007-09-07 Inactivated poliovirus vaccine

Country Status (5)

Country Link
CN (2) CN101534854A (en)
ES (1) ES2365557T5 (en)
GB (1) GB0617602D0 (en)
UA (2) UA97376C2 (en)
ZA (2) ZA200901530B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0716519A2 (en) 2006-09-07 2013-10-08 Glaxosmithkline Biolog Sa METHOD FOR MANUFACTURING A VACCINE
CN112138155B (en) * 2019-06-28 2022-04-12 怡道生物科技(苏州)有限公司 Compound adjuvant system and method for preparing adjuvant
CN111467488B (en) * 2020-04-17 2023-09-01 内蒙古必威安泰生物科技有限公司 Water-soluble composite immunoadjuvant and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2289548A3 (en) * 1992-05-23 2012-08-08 GlaxoSmithKline Biologicals S.A. Combined vaccines comprising hepatitis B surface antigen and other antigens
BR9710460A (en) * 1996-07-02 1999-08-17 Connaught Lab Multivalent immunological composition and its use in vaccines
GB9806456D0 (en) * 1998-03-25 1998-05-27 Smithkline Beecham Biolog Vaccine composition

Also Published As

Publication number Publication date
CN101534855A (en) 2009-09-16
UA95810C2 (en) 2011-09-12
ES2365557T5 (en) 2016-12-07
CN101534855B (en) 2017-08-01
ES2365557T3 (en) 2011-10-06
CN101534854A (en) 2009-09-16
ZA200901592B (en) 2010-06-30
GB0617602D0 (en) 2006-10-18
ZA200901530B (en) 2010-05-26

Similar Documents

Publication Publication Date Title
HK1129563A1 (en) Inactivated poliovirus combination vaccine
WO2007002470A3 (en) Inactivated chimeric vaccines and related methods of use
IL168584A (en) West nile virus vaccine
PH12015501637A1 (en) Inactivated dengue virus vaccine with aluminium-free adjuvant
NO20070551L (en) Vaccine Compositions and Methods for Treating Coronavirus Infection.
MY149604A (en) C.perfringens alpha toxoid vaccine
NZ607477A (en) Non-natural amino acid replication-dependent microorganisms and vaccines
WO2009032913A3 (en) Thermal inactivation of rotavirus
MY172788A (en) Influenza vaccines
UA97376C2 (en) Vaccine
GB0507632D0 (en) Vaccine
WO2011074006A3 (en) Vaccine composition
WO2007028985A3 (en) Adjuvanted vaccine
BRPI0713274A2 (en) combination of vaccines for the protection of fish against streptococcal infection, and method for preparing a combination of vaccines
DE602005012401D1 (en) Alpha-defensine als anthrax-immuntherapeutika
WO2007147518A3 (en) Use of ppd for the adjuvantation of a nucleic acid vaccine
UA4626U (en) Bivalent inactivated concentrate-vaccine against infectious rhinotracheitis and viral diarrhea of the cattle